Quantitative mass spectrometric immunoassay for the chemokine RANTES and its variants

Olgica Trenchevska, Nisha D. Sherma, Paul E. Oran, Peter D. Reaven, Randall W. Nelson, Dobrin Nedelkov

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The chemokine RANTES plays a key role in inflammation, cell recruitment and T cell activation. RANTES is heterogenic and exists as multiple variants in vivo. Herein we describe the development and characterization of a fully quantitative mass spectrometric immunoassay (MSIA) for analysis of intact RANTES and its proteoforms in human serum and plasma samples. The assay exhibits linearity over a wide concentration range (1.56-200. ng/mL), intra- and inter-assay precision with CVs <. 10%, and good linearity and recovery correlations. The assay was tested in different biological matrices, and it was benchmarked against an existing RANTES ELISA. The new RANTES MSIA was used to analyze RANTES and its proteoforms in a small clinical cohort, revealing the quantitative distribution and frequency of the native and truncated RANTES proteoforms. Biological significance: In the last two decades, RANTES has been studied extensively due to its association with numerous clinical conditions, including kidney-related, autoimmune, cardiovascular, viral and metabolic pathologies. Although a single gene product, RANTES is expressed in a range of cells and tissues presenting with different endogenously produced variants and PTMs. The structural variety and population diversity that has been identified for RANTES necessitate developing advanced methodologies that can provide insight into the protein heterogeneity and its function and regulation in disease. In this work we present a simple, efficient and high-throughput mass spectrometric immunoassay (MSIA) method for analysis of RANTES proteoforms. RANTES MSIA can detect and analyze RANTES proteoforms and provide an insight into the endogenous protein modifications.

Original languageEnglish (US)
Pages (from-to)15-23
Number of pages9
JournalJournal of Proteomics
Volume116
DOIs
StatePublished - Feb 6 2015

Fingerprint

Chemokine CCL5
Chemokines
Immunoassay
Assays
Pulse time modulation
T-cells
Pathology

Keywords

  • Chemokine
  • Mass spectrometric immunoassay
  • Quantitative analysis
  • RANTES

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics

Cite this

Trenchevska, O., Sherma, N. D., Oran, P. E., Reaven, P. D., Nelson, R. W., & Nedelkov, D. (2015). Quantitative mass spectrometric immunoassay for the chemokine RANTES and its variants. Journal of Proteomics, 116, 15-23. https://doi.org/10.1016/j.jprot.2014.12.011

Quantitative mass spectrometric immunoassay for the chemokine RANTES and its variants. / Trenchevska, Olgica; Sherma, Nisha D.; Oran, Paul E.; Reaven, Peter D.; Nelson, Randall W.; Nedelkov, Dobrin.

In: Journal of Proteomics, Vol. 116, 06.02.2015, p. 15-23.

Research output: Contribution to journalArticle

Trenchevska, O, Sherma, ND, Oran, PE, Reaven, PD, Nelson, RW & Nedelkov, D 2015, 'Quantitative mass spectrometric immunoassay for the chemokine RANTES and its variants', Journal of Proteomics, vol. 116, pp. 15-23. https://doi.org/10.1016/j.jprot.2014.12.011
Trenchevska, Olgica ; Sherma, Nisha D. ; Oran, Paul E. ; Reaven, Peter D. ; Nelson, Randall W. ; Nedelkov, Dobrin. / Quantitative mass spectrometric immunoassay for the chemokine RANTES and its variants. In: Journal of Proteomics. 2015 ; Vol. 116. pp. 15-23.
@article{ffe7a4db25d94438bd10675fe55a34b2,
title = "Quantitative mass spectrometric immunoassay for the chemokine RANTES and its variants",
abstract = "The chemokine RANTES plays a key role in inflammation, cell recruitment and T cell activation. RANTES is heterogenic and exists as multiple variants in vivo. Herein we describe the development and characterization of a fully quantitative mass spectrometric immunoassay (MSIA) for analysis of intact RANTES and its proteoforms in human serum and plasma samples. The assay exhibits linearity over a wide concentration range (1.56-200. ng/mL), intra- and inter-assay precision with CVs <. 10{\%}, and good linearity and recovery correlations. The assay was tested in different biological matrices, and it was benchmarked against an existing RANTES ELISA. The new RANTES MSIA was used to analyze RANTES and its proteoforms in a small clinical cohort, revealing the quantitative distribution and frequency of the native and truncated RANTES proteoforms. Biological significance: In the last two decades, RANTES has been studied extensively due to its association with numerous clinical conditions, including kidney-related, autoimmune, cardiovascular, viral and metabolic pathologies. Although a single gene product, RANTES is expressed in a range of cells and tissues presenting with different endogenously produced variants and PTMs. The structural variety and population diversity that has been identified for RANTES necessitate developing advanced methodologies that can provide insight into the protein heterogeneity and its function and regulation in disease. In this work we present a simple, efficient and high-throughput mass spectrometric immunoassay (MSIA) method for analysis of RANTES proteoforms. RANTES MSIA can detect and analyze RANTES proteoforms and provide an insight into the endogenous protein modifications.",
keywords = "Chemokine, Mass spectrometric immunoassay, Quantitative analysis, RANTES",
author = "Olgica Trenchevska and Sherma, {Nisha D.} and Oran, {Paul E.} and Reaven, {Peter D.} and Nelson, {Randall W.} and Dobrin Nedelkov",
year = "2015",
month = "2",
day = "6",
doi = "10.1016/j.jprot.2014.12.011",
language = "English (US)",
volume = "116",
pages = "15--23",
journal = "Journal of Proteomics",
issn = "1874-3919",
publisher = "Elsevier",

}

TY - JOUR

T1 - Quantitative mass spectrometric immunoassay for the chemokine RANTES and its variants

AU - Trenchevska, Olgica

AU - Sherma, Nisha D.

AU - Oran, Paul E.

AU - Reaven, Peter D.

AU - Nelson, Randall W.

AU - Nedelkov, Dobrin

PY - 2015/2/6

Y1 - 2015/2/6

N2 - The chemokine RANTES plays a key role in inflammation, cell recruitment and T cell activation. RANTES is heterogenic and exists as multiple variants in vivo. Herein we describe the development and characterization of a fully quantitative mass spectrometric immunoassay (MSIA) for analysis of intact RANTES and its proteoforms in human serum and plasma samples. The assay exhibits linearity over a wide concentration range (1.56-200. ng/mL), intra- and inter-assay precision with CVs <. 10%, and good linearity and recovery correlations. The assay was tested in different biological matrices, and it was benchmarked against an existing RANTES ELISA. The new RANTES MSIA was used to analyze RANTES and its proteoforms in a small clinical cohort, revealing the quantitative distribution and frequency of the native and truncated RANTES proteoforms. Biological significance: In the last two decades, RANTES has been studied extensively due to its association with numerous clinical conditions, including kidney-related, autoimmune, cardiovascular, viral and metabolic pathologies. Although a single gene product, RANTES is expressed in a range of cells and tissues presenting with different endogenously produced variants and PTMs. The structural variety and population diversity that has been identified for RANTES necessitate developing advanced methodologies that can provide insight into the protein heterogeneity and its function and regulation in disease. In this work we present a simple, efficient and high-throughput mass spectrometric immunoassay (MSIA) method for analysis of RANTES proteoforms. RANTES MSIA can detect and analyze RANTES proteoforms and provide an insight into the endogenous protein modifications.

AB - The chemokine RANTES plays a key role in inflammation, cell recruitment and T cell activation. RANTES is heterogenic and exists as multiple variants in vivo. Herein we describe the development and characterization of a fully quantitative mass spectrometric immunoassay (MSIA) for analysis of intact RANTES and its proteoforms in human serum and plasma samples. The assay exhibits linearity over a wide concentration range (1.56-200. ng/mL), intra- and inter-assay precision with CVs <. 10%, and good linearity and recovery correlations. The assay was tested in different biological matrices, and it was benchmarked against an existing RANTES ELISA. The new RANTES MSIA was used to analyze RANTES and its proteoforms in a small clinical cohort, revealing the quantitative distribution and frequency of the native and truncated RANTES proteoforms. Biological significance: In the last two decades, RANTES has been studied extensively due to its association with numerous clinical conditions, including kidney-related, autoimmune, cardiovascular, viral and metabolic pathologies. Although a single gene product, RANTES is expressed in a range of cells and tissues presenting with different endogenously produced variants and PTMs. The structural variety and population diversity that has been identified for RANTES necessitate developing advanced methodologies that can provide insight into the protein heterogeneity and its function and regulation in disease. In this work we present a simple, efficient and high-throughput mass spectrometric immunoassay (MSIA) method for analysis of RANTES proteoforms. RANTES MSIA can detect and analyze RANTES proteoforms and provide an insight into the endogenous protein modifications.

KW - Chemokine

KW - Mass spectrometric immunoassay

KW - Quantitative analysis

KW - RANTES

UR - http://www.scopus.com/inward/record.url?scp=84920973174&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920973174&partnerID=8YFLogxK

U2 - 10.1016/j.jprot.2014.12.011

DO - 10.1016/j.jprot.2014.12.011

M3 - Article

VL - 116

SP - 15

EP - 23

JO - Journal of Proteomics

JF - Journal of Proteomics

SN - 1874-3919

ER -